The company has developed the anti malarial drug by utilizing its Dose Optimization Technology under the Novel Drug Delivery System (NDDS).
ARH 1 carries Arteether 150mg/ml and is produced by using solubility technique.
The clinical trials have demonstrated efficacy of the anti malarial drug as compared to the available brands in the market.
Lincoln Pharma MD Mahendra Patel said the company is about providing healthcare for all, the launch of ARH 1 is yet another innovative drug that has been created in line with their mantra and they are very excited about its introduction.
"With ARH 1 we are now the first company in India to provide an enhanced treatment for severe malaria," Patel said.